Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 May;1(3):304–309. doi: 10.1128/cdli.1.3.304-309.1994

T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis.

A M Cooper 1, P C Melby 1, C L Karp 1, F Neva 1, D L Sacks 1
PMCID: PMC368253  PMID: 7496967

Abstract

Although there is strong evidence that the control and resolution of human leishmanial infections depend primarily on activation of parasite-infected macrophages mediated by lymphokines derived from T cells, less is known about the nature of the responding cell type(s) which is protective or the antigen(s) (Ag[s]) that elicits these cells to respond. Studies using preparations of whole soluble Ag ("dead Ag") show that patients respond to a wide range of leishmanial Ags. The objective of the present study was to characterize the response of T cells from patients with healing or healed cutaneous or mucosal infections to Ag expressed by or derived from actively infected autologous monocytes ("live Ag"). Unfractionated T cells proliferated and produced gamma interferon in response to both live and dead Ags. Depletion of CD4+ T cells resulted in the loss of proliferative and gamma interferon responses to both live and dead Ags. The effect of CD8 depletion, although variable and not limited to the cells stimulated by infected monocytes, was clear for some patients. Expansion of T cells specific for live Ags by using amastigote-infected cells followed by restimulation with fast-protein liquid chromatography-fractionated soluble Ags revealed that a diversity of Ags are associated with infected monocytes. There may, however, be quantitative differences in the expression of certain Ags since prestimulation with live Ag induced higher responses to restimulation in mucocutaneous leishmaniasis patients than in localized cutaneous leishmaniasis patients. Prestimulation with dead Ag induced similar secondary responses in both patient groups.

Full text

PDF
304

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carvalho E. M., Johnson W. D., Barreto E., Marsden P. D., Costa J. L., Reed S., Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol. 1985 Dec;135(6):4144–4148. [PubMed] [Google Scholar]
  2. Cillari E., Milano S., Dieli M., Maltese E., Di Rosa S., Mansueto S., Salerno A., Liew F. Y. Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis. J Immunol. 1991 Feb 1;146(3):1026–1030. [PubMed] [Google Scholar]
  3. Conceiço-Silva F., Dórea R. C., Pirmez C., Schubach A., Coutinho S. G. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis. Clin Exp Immunol. 1990 Feb;79(2):221–226. doi: 10.1111/j.1365-2249.1990.tb05182.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farrell J. P., Muller I., Louis J. A. A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice. J Immunol. 1989 Mar 15;142(6):2052–2056. [PubMed] [Google Scholar]
  5. Mahanty S., Abrams J. S., King C. L., Limaye A. P., Nutman T. B. Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol. 1992 Jun 1;148(11):3567–3571. [PubMed] [Google Scholar]
  6. Marsden P. D. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg. 1986;80(6):859–876. doi: 10.1016/0035-9203(86)90243-9. [DOI] [PubMed] [Google Scholar]
  7. Melby P. C., Neva F. A., Sacks D. L. Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting. J Clin Invest. 1989 Jun;83(6):1868–1875. doi: 10.1172/JCI114093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Melby P. C., Sacks D. L. Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting. Infect Immun. 1989 Oct;57(10):2971–2976. doi: 10.1128/iai.57.10.2971-2976.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mendonça S. C., Russell D. G., Coutinho S. G. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin Exp Immunol. 1991 Mar;83(3):472–478. doi: 10.1111/j.1365-2249.1991.tb05663.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murray H. W., Rubin B. Y., Rothermel C. D. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest. 1983 Oct;72(4):1506–1510. doi: 10.1172/JCI111107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Müller I., Louis J. A. Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites. Eur J Immunol. 1989 May;19(5):865–871. doi: 10.1002/eji.1830190513. [DOI] [PubMed] [Google Scholar]
  12. Pirmez C., Cooper C., Paes-Oliveira M., Schubach A., Torigian V. K., Modlin R. L. Immunologic responsiveness in American cutaneous leishmaniasis lesions. J Immunol. 1990 Nov 1;145(9):3100–3104. [PubMed] [Google Scholar]
  13. Reed S. G., Carvalho E. M., Sherbert C. H., Sampaio D. P., Russo D. M., Bacelar O., Pihl D. L., Scott J. M., Barral A., Grabstein K. H. In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J Clin Invest. 1990 Mar;85(3):690–696. doi: 10.1172/JCI114493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Reiner N. E., Ng W., Wilson C. B., McMaster W. R., Burchett S. K. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1. J Clin Invest. 1990 Jun;85(6):1914–1924. doi: 10.1172/JCI114654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ridley D. S., Ridley M. J. The evolution of the lesion in cutaneous leishmaniasis. J Pathol. 1983 Sep;141(1):83–96. doi: 10.1002/path.1711410109. [DOI] [PubMed] [Google Scholar]
  16. Ridley M. J., Wells C. W. Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study. Am J Pathol. 1986 Apr;123(1):79–85. [PMC free article] [PubMed] [Google Scholar]
  17. Scott P., Pearce E., Natovitz P., Sher A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol. 1987 Jul 1;139(1):221–227. [PubMed] [Google Scholar]
  18. Scott P. The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis. Exp Parasitol. 1989 Apr;68(3):369–372. doi: 10.1016/0014-4894(89)90120-3. [DOI] [PubMed] [Google Scholar]
  19. Smith L. E., Rodrigues M., Russell D. G. The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages. J Exp Med. 1991 Sep 1;174(3):499–505. doi: 10.1084/jem.174.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wyler D. J., Weinbaum F. I., Herrod H. R. Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens. J Infect Dis. 1979 Aug;140(2):215–221. doi: 10.1093/infdis/140.2.215. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES